GlassScriptPhysician profile
Muhammad J Habib
NPI 1871856351
$15,535.10
in general payments reported to CMS, 2019-2025
48 companies · $2,632 in 2025
The $2,632 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $1,549 · 2021: $2,584 · 2022: $2,267 · 2023: $2,976 · 2024: $2,518 · 2025: $2,632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,019 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,019.12 |
| Education | $106.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,323.97 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $2,277.07 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $1,153.28 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $933.85 | 2020-2025 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $868.28 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Regeneron Healthcare Solutions, INC. | $719.57 | 2020-2025 | Dupixent |
| United Therapeutics Corporation | $623.20 | 2021-2025 | Tyvaso, Tyvaso, Orenitram |
| Grifols USA, LLC | $584.60 | 2019-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $556.47 | 2021-2025 | Xywav |
| Actelion Pharmaceuticals US, INC. | $505.04 | 2019-2025 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $443.57 | 2020-2024 | Yupelri |
| Insmed, INC. | $439.26 | 2019-2025 | Arikayce, Brinsupri |
| Paratek Pharmaceuticals, INC. | $367.87 | 2020-2025 | Nuzyra |
| Janssen Pharmaceuticals, INC | $316.48 | 2019-2023 | Xarelto |
| Sunovion Pharmaceuticals INC. | $301.33 | 2019-2021 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $283.64 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $236.84 | 2019-2023 | Opdivo, Eliquis |
| Teva Pharmaceuticals USA, INC. | $181.78 | 2020-2023 | Airduo Digihaler |
| Sanofi-Aventis U.S. LLC | $172.50 | 2020-2025 | |
| Pfizer INC. | $171.23 | 2019-2025 | |
| Philips North America LLC | $165.00 | 2019-2024 | (Ak6) Vest Therapy |
| Amgen INC. | $160.96 | 2023-2025 | Tezspire |
| Csl Behring | $157.70 | 2022-2025 | Hizentra |
| Merck Sharp & Dohme LLC | $150.36 | 2019-2025 | Winrevair |
| Baxter Healthcare | $149.30 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Viatris Specialty LLC | $122.75 | 2025 | Yupelri |
| Genentech USA, INC. | $114.30 | 2019-2025 | Xolair |
| Gilead Sciences, INC. | $103.11 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $102.74 | 2024-2025 | Lumryz |
| Harmony Biosciences LLC | $88.03 | 2023-2025 | Wakix |
| Covis Pharma Gmbh | $81.27 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $79.25 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.91 | 2022-2023 | |
| Lilly USA, LLC | $69.15 | 2025 | Zepbound |
| Idorsia Pharmaceuticals US INC | $68.20 | 2022-2023 | Quviviq |
| Inari Medical, INC. | $55.76 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pulmonx Corporation | $48.22 | 2019-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Fisher & Paykel Healthcare INC | $46.27 | 2025 | Fisher & Paykel Healthcare |
| Abbott Laboratories | $42.62 | 2023 | Cardiomems |
| Resmed Corp | $33.61 | 2022-2024 | |
| Inspire Medical Systems, INC. | $33.21 | 2023-2024 | Inspire |
| Allergan, INC. | $25.46 | 2019-2020 | |
| Tactile Systems Technology INC | $24.34 | 2023 | Flexitouch Plus, Entre Plus |
| Shire North American Group INC | $24.31 | 2019 | |
| Electromed, INC. | $21.84 | 2025 | Smartvest |
| Inogen, INC. | $16.84 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Chiesi USA, INC. | $15.76 | 2024 | Cleviprex |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Habib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.